Guy Sauvageau, Josée Hébert and colleagues analyze exomes and transcriptomes in MLL-rearranged acute myeloid leukemias. They find frequent RAS pathway mutations, which sensitize leukemias to MEK and receptor tyrosine kinase inhibitors.
- Vincent-Philippe Lavallée
- Irène Baccelli
- Guy Sauvageau